Call Start: 08:30 January 1, 0000 9:16 AM ET
The Chemours Company (NYSE:CC)
Q1 2022 Earnings Conference Call
May 3, 2022, 8:30 AM ET
Company Participants
Mark Newman – President, Chief Executive Officer
Sameer Ralhan – Senior Vice President, Chief Financial Officer
Jonathan Lock – Senior Vice President, Chief Development Officer
Conference Call Participants
John McNulty – BMO Capital Markets
Arun Viswanathan – RBC Capital Markets
James Cannon – UBS
Michael Leithead – Barclays
Hassan Ahmed – Alembic Global Advisors
Matthew DeYoe – Bank of America
Eric Petrie – Citi
Kevin Estok – Jefferies
William Tang – Morgan Stanley
Operator
Good morning. My name is Emma and I'll be your conference operator today. At this time, I would like to welcome everyone to the Chemours Company First-Quarter 2022 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers ' remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply [Operator Instructions] If you'd like to address your question, again, [Operator Instructions] Thank you. Jonathan Lock, Senior Vice President and Chief Development Officer. You may begin.
Jonathan Lock
Hi. Welcome to the Chemours Company's First-Quarter 2022 Earnings Conference Call. I'm joined today by Mark Newman, President and Chief Executive Officer and Sameer Ralhan, Senior Vice President and Chief Financial Officer. Before we start, I'd like to remind you that comments made on this call as well as the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties, including the impact of COVID-19 on our business and operation and the other risks and uncertainties described in the documents Chemours has filed with the SEC. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events that may not be realized.
Actual results may differ and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information. During the course of this call, management will refer to certain non-GAAP financial measures that we believe are useful to investors evaluating the company's performance. A reconciliation of non-GAAP terms and adjustments are included in our release and at the end of the presentation. As a reminder, our prepared remarks, a full transcript, and an audio recording plus our earnings deck has been posted to our website alongside our earnings release. This morning's call will focus purely on Q&A. With that, I'll turn the call over to our CEO, Mark Newman.